歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > Membranetransporter/Ionchannel > Fatostatin A

瀏覽歷史

S82581

Fatostatin A

源葉(MedMol) 99%
  • 英文名:
  • Fatostatin A
  • 別名:
  • Hexatype Brown N; Typogen Brown N; Resinol RRN; Solvent Brown 1; fatostatin A; Sudan Brown YR; Sudan Brown RR; Fat Brown RR; 1-naphthylamin->m-phenylendiamin; C.I. Solvent Brown 1; 4-naphthalen-1-yl-d
  • CAS號:
  • 125256-00-0
  • 分子式:
  • C18H18N2S
  • 分子量:
  • 294.4139
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S82581-5mg 99% ¥255.00元 2 - - - EA 加入購物車
源葉(MedMol) S82581-10mg 99% ¥425.00元 6 - - - EA 加入購物車
源葉(MedMol) S82581-25mg 99% ¥540.00元 3 - - - EA 加入購物車
源葉(MedMol) S82581-50mg 99% ¥867.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S82581-100mg 99% ¥1190.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(1篇)

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Fatostatin (125B11) 是一種diarylthiazole的衍生物,是 Sterol regulatory element binding proteins (SREBPs) 活化的特異性抑制劑。Fatostatin 可結(jié)合SCAP (SREBP cleavage-activating protein),并抑制SREBP的ER-Golgi易位。Fatostatin 可抑制癌細胞生長并增強癌細胞的凋亡
  • 靶點: SREBP;NPC1L1;?FattyAcidSynthase
  • 體外研究:
    Fatostatin impairs the activation process of sterol regulatory element binding proteins (SREBPs), thereby decreasing the transcription of lipogenic genes in cells. Fatostatin inhibits the ER-Golgi translocation of SREBPs through binding to their escort protein, the SREBP cleavage-activating protein (SCAP), at a distinct site from the sterol-binding domain
  • 體內(nèi)研究:
    Fatostatin blocks increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake. Fatostatin may serve as a tool for gaining further insights into the regulation of SREBP
  • 細胞實驗: Cell lines: CHO-K1 cells Concentrations: 20 μM Incubation Time: 20 h Method: CHO-K1 cells are plated out onto a 96-well plate in medium A. The cells are transiently cotransfected with pCMV-PLAP-BP2, pCMV-SCAP, and pAc-b-gal, using Lipofectamine reagent. After incubation for 5 hr, the cells are washed with PBS and then incubated in medium B, in the absence or presence of fatostatin (20 μM) or sterols (10 μg/mL cholesterol and 1 μg/mL 25-hydroxycholesterol). After 20 hr of incubation, an aliquot of the medium is assayed for secreted alkaline phosphatase activity. The cells in each well are lysed and used for measurement of b-galactosidase activities. The alkaline phosphatase activity is normalized by the activity of b-galactosidase.
  • 動物實驗: Animal Models: 4-to-5-week-old homozygous male obese (ob/ob) mice (C57BL/6J) Dosages: 30 mg/kg Administration: IP
  • 參考文獻:
    1. Shinji Kamisuki, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009 Aug 28;16(8):882-92. 2. Shuhong Gao, et al. Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. Oncol Rep. 2018 Apr;39(4):1919-1929.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 3.397 ml 16.983 ml 33.966 ml
    5 mM 0.679 ml 3.397 ml 6.793 ml
    10 mM 0.34 ml 1.698 ml 3.397 ml
    50 mM 0.068 ml 0.34 ml 0.679 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。